Skip to main content

Table 1 Population characteristics. Results expressed in numbers (percentages) except *median and interquartile interval [1st–3rd]. IAI intraabdominal infection

From: Impact of species and antibiotic therapy of enterococcal peritonitis on 30-day mortality in critical care—an analysis of the OUTCOMEREA database

Variables All IAI with Enterococcus spp. (n = 76)
Age (years)* 71.7 [59.0–78.1]
Gender (M/F) 43/33
Day 0 SAPS score* 48 [37–57]
Immunocompromised status 20 (26.3%)
Hospital admission-IAI time* 8 [2–18]
ICU admission-IAI time* 1 [1–4]
IAI diagnosis-surgery time 0 [0–0]
E. faecium 28 (36.8%)
E. faecalis 46 (60.5%)
Other Enterococcus spp. 9 (11.8%)
ICU acquired 24 (31.6%)
Nosocomial 68 (89.5%)
Postoperative 53 (69.7%)
Enterococcal bacteremia 4 (5.3%)
Septic shock at time of IAI diagnosis 53 (69.7%)
Source control
 Surgery 74 (97.4%)
 Percutaneous drainage 2 (2.6%)
IAI anatomical origin
 Colon 32 (42.7%)
 Small intestine 19 (25.3%)
 Hepatobiliary 12 (16%)
 Gastroduodenal 8 (10.7%)
Pathophysiology of IAI
 Perforation 22 (28.9%)
 Intraabdominal abscess 27 (35.5%)
 Fistula 26 (34.2%)
 Necrosis 19 (25.0%)
Surgical complications 35 (46.1%)
 Intraabdominal abscess 20 (26.3%)
 Wound infection 19 (25.0%)
 Fistula 8 (10.5%)
 Suture line disruption 2 (2.6%)
 Evisceration 1 (1.3%)
Relaparotomy or percutaneous drainage at day 30 23 (30.3%)
IAI-relaparotomy or IAI-percutaneous drainage time (days)* 10 [6–20]
Tertiary peritonitis 16 (21.3%).
Postoperative infectious complications at day 30 24 (31.6%)
Septic shock at day 30 44 (57.9%)
Mortality at day 30 17 (22.4%)